Peter Mustillo
Immunology and Microbiology · The Ohio State University
Publications
48
Citations
1,579
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2002
Peter Mustillo studies inborn errors of immunity, which are genetic conditions that impair the immune system, with particular attention to conditions like 22q11.2 deletion syndrome (DiGeorge syndrome), primary immunodeficiencies, and rare genetic mutations affecting immune cell signaling. His work spans clinical case reports, guideline development, and collaborative genetic/molecular studies, often examining how immune dysfunction relates to infections, autoimmunity, and vaccine responses (including COVID-19). This research combines clinical immunology with basic science to better diagnose and manage patients with rare immune disorders.
Publication output has fluctuated over the past decade but shows a generally steady-to-growing pattern, peaking in 2024 with 7 publications after a dip in 2022.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Immunologic Manifestations Of Distal 22q11.2 Deletion
Journal of Allergy and Clinical Immunology · 2026
- A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesis
Annals of the Rheumatic Diseases · 2025
- A De Novo Dominant-Negative PSMB8 Mutation Causes Severe CANDLE/PRAAS Due to Arrested Proteasome Biogenesis
SSRN Electronic Journal · 2025
- DIGEORGE SYNDROME: WHEN GENETIC TESTING IS ELUSIVE
Annals of Allergy Asthma & Immunology · 2025
- Germline mutations in a G protein identify signaling cross-talk in T cells
Science · 2024
- COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report
Journal of Clinical Immunology · 2024
- PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells
Nature Immunology · 2024
- Correction to: Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development
Journal of Clinical Immunology · 2024
- COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report
Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2024
- STK4 DEFICIENCY: EXPANDING THE DIFFERENTIAL OF HYPER-IGE IMMUNODEFICIENCIES
Annals of Allergy Asthma & Immunology · 2024
- Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Nature · 2023
- Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development
Journal of Clinical Immunology · 2023
- Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-kB pathway
2023
- Timing of Allergy Skin Testing Following Food-Induced Anaphylaxis
Journal of Allergy and Clinical Immunology · 2022
- Infectious Complications Predict Premature CD8+ T-cell Senescence in CD40 Ligand-Deficient Patients
Journal of Clinical Immunology · 2021
- Journal of Allergy and Clinical Immunology×12
- Annals of Allergy Asthma & Immunology×5
- Journal of Clinical Immunology×4
- Nature×1
- Nature Communications×1
- Roshini S. Abraham
Immunology and Microbiology · The Ohio State University
- Kelsey Lecerf
Immunology and Microbiology · The Ohio State University
- William H. Marshall
Immunology and Microbiology · The Ohio State University
- Benjamin T. Prince
Medicine · The Ohio State University
- Chang H. Kim
Immunology and Microbiology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile